Thomas Nusbickel, Chief Commercial Officer, Celltrion USA
Advertisement
Articles by Thomas Nusbickel, Chief Commercial Officer, Celltrion USA
Advertisement
Latest Updated Articles
- Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars
Published: July 5th 2023 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
PBM reform. It has finally happened
3
TrumpRx launches; some experts question its long-term value
4
Cancer survival fell and deaths rose during first two years of COVID-19
5